Assessment of Contact Lens Wettability Using Wavefront Aberrometry

June 18, 2018 updated by: Johnson & Johnson Vision Care, Inc.
This study will test the feasibility that differences in contact lens wettability can be measured with a wavefront sensor.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

25

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Queensland
      • Kelvin Grove, Queensland, Australia, 4059

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Healthy males or females that are at least 18 to no more than 40 years of age.
  2. The subject must read, understand, and sign the Statement of Informed Consent and receive a fully executed copy of the form.
  3. The subject must appear able and willing to adhere to the instructions set forth in this clinical protocol.
  4. The subject must possess a wearable pair of spectacles with distance vision correction which provide satisfactory vision.
  5. The subject is a current spherical soft contact lens wearer (defined as a minimum of 6 hours of lens wear per week for a minimum of 1 month prior to the study) or has sufficient prior experience with soft contact lens wear (defined as a minimum of 30 days of lens wear during the last 5 years).
  6. The subject's vertexed best sphere distance refraction must be between -0.75 and -5.00 D in both eyes.
  7. Cylinder refraction less than or equal to -0.75 D in both eyes (any axis).
  8. The subject must have corrected visual acuity of 20/20 or better in each eye.

Exclusion Criteria:

  1. Currently pregnant or lactating (subjects who become pregnant during the study will be discontinued).
  2. Any ocular or systemic allergies or diseases that may interfere with contact lens wear.
  3. Any systemic disease, autoimmune disease, or use of medication, which may interfere with contact lens wear.
  4. Any known hypersensitivity or allergic reaction to contact lens solutions or sodium fluorescein dye.
  5. Any previous ocular or intraocular surgery (e.g. radial keratotomy, PRK, LASIK, etc.)
  6. Current wearers of rigid or hybrid contact lenses.
  7. Entropion, ectropion, extrusions, chalazia, recurrent styes, glaucoma, history of recurrent corneal erosions, aphakia, or moderate or above corneal distortion by keratometry.
  8. Infectious diseases (e.g. hepatitis, tuberculosis) or an immuno-suppressive disease (e.g. HIV).
  9. History of binocular vision abnormality or strabismus.
  10. Employee of the investigational clinic (e.g. Investigator, Coordinator, Technician).
  11. Clinically significant (grade 3 or 4) corneal edema, pterygium, corneal vascularization, corneal staining, or any other abnormalities of the cornea or conjunctiva which may interfere with the study measurements.
  12. Strabismus, suppression or amblyopia.
  13. Any ocular infection.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: senofilcon A
The lenses will be worn for 2 hours in both eyes, and not dispensed
A soft spherical contact lens
Active Comparator: lotrafilcon A
The lenses will be worn for 2 hours in both eyes, and not dispensed
A soft spherical contact lens

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Higher Order Root Mean Square (HO RMS) - Near Target in Downgaze With Natural Blinking
Time Frame: 2 hours post insertion
Wavefront metric measured by COAS wavefront sensor while subject fixates a near digital device in a down-gaze position with natural blinking. The average HO RMS was reported for each lens. Lower values indicate better outcome.
2 hours post insertion
Higher Order Root Mean Square (HO RMS) - Near Target in Downgaze With Controlled Blink
Time Frame: 2 hours post insertion
Wavefront metric measured by COAS wavefront sensor while subject fixates a near digital device in a down-gaze position with controlled blinking. The average HO RMS was reported for each lens. Lower values indicate better outcome.
2 hours post insertion
Higher Order Root Mean Square (HO RMS) - Distance Target in Primary Gaze With Controlled Blink
Time Frame: 2 hours post insertion
Wavefront metric measured by COAS wavefront sensor while subject fixates a distant target in primary gaze with controlled blinking. The average HO RMS was reported for each lens. Lower values indicate better outcome.
2 hours post insertion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2014

Primary Completion (Actual)

May 1, 2015

Study Completion (Actual)

May 1, 2015

Study Registration Dates

First Submitted

January 22, 2015

First Submitted That Met QC Criteria

January 27, 2015

First Posted (Estimate)

January 28, 2015

Study Record Updates

Last Update Posted (Actual)

June 19, 2018

Last Update Submitted That Met QC Criteria

June 18, 2018

Last Verified

November 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • CR-5685

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Visual Acuity

Clinical Trials on lotrafilcon B

Subscribe